Patents by Inventor Doris Peterkin

Doris Peterkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE VACCINES AND PEMBROLIZUMAB FOR TREATING BREAST CANCER
    Publication number: 20250018031
    Abstract: The disclosure features, inter alia, combination therapies comprising pembrolizumab and one or more immunogenic XBP1-, CD138-, and CS1-derived peptides. The therapies herein can be used, e.g., for inducing an immune response in a subject having a cancer, and treating a cancer such as breast cancer, e.g., triple negative breast cancer.
    Type: Application
    Filed: July 3, 2024
    Publication date: January 16, 2025
    Inventors: Doris Peterkin, Marc A. Cohen
  • Peptide vaccines and pembrolizumab for treating breast cancer
    Patent number: 12059463
    Abstract: The disclosure features, inter alia, combination therapies comprising pembrolizumab and one or more immunogenic XBP1-, CD138-, and CS1-derived peptides. The therapies herein can be used, e.g., for inducing an immune response in a subject having a cancer, and treating a cancer such as breast cancer, e.g., triple negative breast cancer.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: August 13, 2024
    Assignee: ONCOPEP, INC.
    Inventors: Doris Peterkin, Marc A. Cohen
  • PEPTIDE VACCINES AND PEMBROLIZUMAB FOR TREATING BREAST CANCER
    Publication number: 20200276304
    Abstract: The disclosure features, inter alia, combination therapies comprising pembrolizumab and one or more immunogenic XBP1-, CD138-, and CS1-derived peptides. The therapies herein can be used, e.g., for inducing an immune response in a subject having a cancer, and treating a cancer such as breast cancer, e.g., triple negative breast cancer.
    Type: Application
    Filed: October 23, 2018
    Publication date: September 3, 2020
    Inventors: Doris Peterkin, Marc A. Cohen
  • PEPTIDE VACCINES AND DURVALUMAB FOR TREATING BREAST CANCER
    Publication number: 20190209669
    Abstract: The disclosure features, inter alia, combination therapies comprising durvalumab and one or more immunogenic XBP1-, CD138-, and CS1-derived peptides. The therapies herein can be used, e.g., for inducing an immune response in a subject having a solid tumor, and treating a solid tumor, e.g., breast cancer, e.g., triple negative breast cancer.
    Type: Application
    Filed: August 22, 2017
    Publication date: July 11, 2019
    Inventors: Doris Peterkin, Marc A. Cohen